Author

Kamil Filipek

University of BolognaORCID 0000-0002-3139-5901Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Assay:proteomics· 1

Frequent Co-Authors

Marianna PenzoiD· 3 shared Daniela PollutriiD· 2 shared Anne-Marie HesseiD· 1 shared Federica ChiapporiiD· 1 shared Giuseppe GasparreiD· 1 shared Israt Jahan Ripa· 1 shared Ivan MerelliiD· 1 shared Ivana KurelaciD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Marianna PenzoORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BioinformaticsbioRxivPreprintMar 11, 2026

Landscape of 8q24.3-Encoded microRNAs and Their Prognostic Impact in Ovarian Cancer

Kamil Filipek, Ivan Merelli, Federica Chiappori, Marianna Penzo

The paper analyzes 8q24.3-encoded microRNAs in ovarian cancer using genomic and transcriptomic data to identify their expression patterns and clinical relevance.

DOI 10.64898/2026.03.06.710032

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyNon-coding RNA ResearchPeer-reviewedNov 5, 2025

miR-6850 Drives Phenotypic Changes and Signaling in High Grade Serous Ovarian Cancer

Kamil Filipek, Daniela Pollutri, Ivana Kurelac…·Marianna Penzo

This study identifies miR-6850 as a tumor-suppressive miRNA in high-grade serous ovarian cancer, showing its anti-oncogenic effects and potential as a biomarker and therapeutic target.

DOI 10.1016/j.ncrna.2025.10.004

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyBiochemical PharmacologyPeer-reviewedOct 31, 2025

Ribosomal protein L5 (RPL5/uL18) I60V mutation is associated to increased translation and modulates drug sensitivity in T-cell acute lymphoblastic leukemia cells

Lorenza Bacci, Daniela Pollutri, Israt Jahan Ripa…·Marianna Penzo

This study investigates the RPL5-I60V mutation in T-ALL, showing it increases translation and alters drug sensitivity in leukemia cells.

2 citations

humanproteomics

𝕏 PostBluesky